Editorial: Predictive Factors and Survival Outcome of Conversion Therapy for Unresectable Hepatocellular Carcinoma Patients Receiving Atezolizumab and Bevacizumab: Comparative Analysis of Conversion, Partial Response and Complete Response Patients. Authors' Reply.
Saved in:
| Title: | Editorial: Predictive Factors and Survival Outcome of Conversion Therapy for Unresectable Hepatocellular Carcinoma Patients Receiving Atezolizumab and Bevacizumab: Comparative Analysis of Conversion, Partial Response and Complete Response Patients. Authors' Reply. |
|---|---|
| Authors: | Hatanaka T; Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Maebashi, Japan., Kakizaki S; Department of Clinical Research, NHO Takasaki General Medical Center, Takasaki, Japan.; Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Maebashi, Japan., Hiraoka A; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan., Tada T; Department of Internal Medicine, Japanese Red Cross Himeji Hospital, Himeji, Japan.; Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan., Kumada T; Gifu Kyoritsu University, Ogaki, Japan. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Nov; Vol. 60 (10), pp. 1469-1470. Date of Electronic Publication: 2024 Oct 04. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
